European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. ACN
8. AZN
9. ORCL
10. HOOD

Go back to European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
(NASDAQ: RVMD) Delayed: 208.80 -1.22 (0.58%)
Previous Close $210.02    52 Week High $ 
Open $208.07    52 Week Low $ 
Day High $213.00    P/E N/A 
Day Low $206.47    EPS $ 
Volume 1,057,568